MedPath

The effects of repetitive peripheral magnetic stimulation on motor function and spasticity in patients with hemiparesis

Phase 4
Conditions
I64
S06.9
Stroke, not specified as haemorrhage or infarction
Intracranial injury, unspecified
Registration Number
DRKS00000798
Lead Sponsor
Schön Klinik Bad Aibling
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
66
Inclusion Criteria

• hemiparesis after stroke or traumatic brain injury
• grade 1 to 3 on Tardieu scale

Exclusion Criteria

• co-morbidity with other degenerative diseases
• implanted medical devices, i.e.
o cardiac pacemaker
o Cochlea- implant
• pregnancy
• metal implants (head and/or stimulation area)
• instabile fractures within stimulation area
• pathological intracraniel pressure

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome parameter is the function and spasticity of the paretic upper extremity. The Fugl-Mayer assessment is used to assess function, and the Tardieu scale to assess spasticity. <br>Both scales will be assessed before therapy, at the end of the 2-week treatment period, and 2 weeks after study treatment. Additionally the Tardieu Scale will be assessed after the first and before the third therapy session to determine any short-term effects.
Secondary Outcome Measures
NameTimeMethod
As secondary outcome the independance in activities of daily living, depression, and the tolerance to the stimulation will be documented. These aspects will assessed by means of the Barthel Index, the 7-item Hamilton Depression Scale, and a self-report questionnaire. Muscle activity of the paretic upper extremity will be measured with electromyography (EMG). All Parameters will be collected before and after the Intervention period, and 2 weeks after study treatment. <br>
© Copyright 2025. All Rights Reserved by MedPath